ProAxsis will be attending the BIO 2016 conference, taking place at the Moscone Convention Center in San Francisco between June 5th-9th 2016.
The BIO International Convention attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. ProAxsis will be attending as part of the Invest Northern Ireland delegation, and will be represented at the meeting by Professor Brian Walker (Chief Scientific Officer) and Dr David Ribeiro (Chief Executive Officer).
Please visit us at the Invest NI stand, which can be found at booth 5858. Alternatively, any enquiries about our immunoassay for measuring neutrophil elastase as a biomarker for lung inflammation and infection, or any other aspects of the company’s proprietary ProteaseTag® technology, can be directed to info@proaxsis.com.
ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.
Related News
In a significant new study, a team at the University of Dundee has shown for the first time that sputum …
ProAxsis will this week be presenting new data on its ProteaseTag® technology, at the North American Cystic Fibrosis Conference …
ProAxsis is pleased to announce the appointment of Sarah Ganniclefft to the newly created role of Sales …
